We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.73B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,278
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPBT
12726
CALL
Purple Biotech
PPBT
$1.31M
$54K ﹤0.01%
+65
New +$60.7K
TRIB
12727
Trinity Biotech
TRIB
$7.83M
$54K ﹤0.01%
+97
New +$70K
EVFM
12728
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$54K ﹤0.01%
+2,050
New +$93.2K
LJPC
12729
PUT
DELISTED
La Jolla Pharmaceutical Company
LJPC
$54K ﹤0.01%
+12,800
New +$70.5K
GALT icon
12730
CALL
Galectin Therapeutics
GALT
$196M
$53K ﹤0.01%
24,500
-27,400
-53% -$61.4K
MSN icon
12731
Emerson Radio
MSN
$7.79M
$53K ﹤0.01%
+41,059
New +$59.1K
QRHC icon
12732
Quest Resource Holding
QRHC
$26.8M
$53K ﹤0.01%
+13,474
New +$41.5K
TLSA icon
12733
PUT
Tiziana Life Sciences
TLSA
$131M
$53K ﹤0.01%
+19,300
New +$64K
TROO icon
12734
TROOPS Inc
TROO
$208M
$53K ﹤0.01%
+24,965
New +$46.4K
TMDI
12735
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$53K ﹤0.01%
31,381
+4,972
+19% +$11.1K
ASC icon
12736
CALL
Ardmore Shipping
ASC
$710M
$52K ﹤0.01%
+11,400
New +$46.2K
STEX
12737
Streamex Corp
STEX
$74M
$52K ﹤0.01%
1,209
-535
-31% -$25K
CPIX icon
12738
Cumberland Pharmaceuticals
CPIX
$100M
$52K ﹤0.01%
+17,005
New +$55.3K
CVV icon
12739
CVD Equipment Corp
CVV
$50M
$52K ﹤0.01%
+11,878
New +$59.1K
DALN
12740
CALL
DELISTED
DallasNews
DALN
$52K ﹤0.01%
+6,275
New +$54.6K
QNRX
12741
Quoin Pharmaceuticals
QNRX
$8.94M
$52K ﹤0.01%
+1
New +$69.8K
TMBR
12742
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$52K ﹤0.01%
+511
New +$44K
JP
12743
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$52K ﹤0.01%
+23,602
New +$57.6K
AXAS
12744
DELISTED
Abraxas Petroleum Corp
AXAS
$52K ﹤0.01%
16,758
+4,367
+35% +$15K
LJPC
12745
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$52K ﹤0.01%
12,300
-2,300
-16% -$12.7K
CLSD
12746
PUT
DELISTED
Clearside Biomedical
CLSD
$51K ﹤0.01%
+1,367
New +$68.6K
GLMD icon
12747
CALL
Galmed Pharmaceuticals
GLMD
$5.13M
$51K ﹤0.01%
+82
New +$56.7K
QUAD icon
12748
CALL
Quad
QUAD
$536M
$51K ﹤0.01%
14,500
+600
+4% +$2.86K
XYF
12749
X Financial
XYF
$190M
$51K ﹤0.01%
+13,776
New +$43.1K
FRBK
12750
CALL
DELISTED
Republic First Bancorp Inc
FRBK
$51K ﹤0.01%
+13,400
New +$45.9K

Similar funds

Citadel Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q1 2021 filing shows 3,278 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
  • Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Citadel Advisors opened 3,278 new positions and closed 1,034 in Q1 2021.
  • Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.